Omni 1000

Percentage of most valuable proteins (MVPs) captured on Omni, curated from top literature, mid-plex panels, endpoint assays, and pharma-preferred pathways to maximize relevance for discovery and development.

Reflects the percentage of top-level biological systems captured on Omni, ensuring full representation across foundational cellular and physiological processes as defined by Reactome’s highest organizational tier.

Represents the proportion of detailed functional pathways covered within each top-level system. This metric captures the depth of Omni’s biological breadth, mapping into specific molecular cascades and processes across human biology.

Tracks Omni’s ability to cover protein markers across all MeSH disease categories, ensuring broad utility for disease biology by aligning with the standard NIH classification of human health conditions.

Measures Omni’s coverage of the 46 most studied KEGG pathways, prioritized based on pharmaceutical pipeline activity, enabling high relevance to drug discovery and translational research across therapeutic areas.

Benchmarked against UK Biobank data, this metric reflects how much of the disease-predictive signal from a large 3,000-protein panel is retained by Omni’s overlapping 800-protein subset.